- Route
- Determined through physician review
- Quantity
- Not established in the public offer
- Laboratory document
- NAD+ report marked upload pending
Reviewing a plan without inventing a formulation
BRAVO1 Wellness has a dedicated NAD+ page with a route-selection discussion and a physician-review entry point. It does not establish one universal vial, bottle or appointment for every customer. This review therefore names the offering as a NAD+ plan and uses the clinician-selected format category instead of assigning an unverified injection or IV specification.
That choice keeps the product review useful without implying that every route mentioned in the educational text is a separately purchasable item at the same price. Ask the clinician which preparation is proposed, who dispenses it and what quantity is included. Those answers are needed before comparing this offer directly with a specified bottle or vial elsewhere.
The two advertised payment choices
The page shows a $175 one-time option and a $165 monthly subscription, a difference of $10 between the displayed numbers. The one-time supply period was not established in the reviewed documentation. It would therefore be premature to call the subscription ten dollars cheaper for an identical month of treatment or to calculate a dependable annual cost.
Request the full initial invoice, the contents of the order and the amount and timing of subsequent charges. In particular, determine whether the assessment, supplies, pharmacy fulfillment and shipping are included. A recurring price can look complete while leaving laboratory work or an additional consultation outside the headline, so unknown fees should not be entered as zero.
What to request from the laboratory library
The provider links to laboratory documentation and describes batch testing. At the check, the public NAD+ entry said upload pending. That is an observable limitation of the available documentation, not a conclusion that testing never occurs. A reader should request the actual certificate relevant to the preparation being offered before relying on the testing claim.
The document should identify the batch and the measurements performed. If the proposed route requires a sterile preparation, questions about sterility, suitable ingredients and handling remain relevant alongside purity or potency. We have not audited the pharmacy, independently sampled a product or established that a general certificate covers the exact finished preparation a patient would receive.
Evaluate the offer after the details are filled in
The sales page discusses the role of NAD+ in cellular processes and possible wellness goals. Those explanations do not establish the outcome of this individualized plan. The clinical conversation should address the intended purpose, evidence for the selected route and the uncertainties that remain. No price or subscription structure resolves those evidence questions.
Once the route and product are identified, ask for storage, delivery and beyond-use information specific to that preparation, together with a clear follow-up contact. Confirm the cancellation point before another pharmacy order begins. The $175 and $165 figures are useful advertised starting information; a fair comparison still requires the actual supply and complete purchase terms, rather than assumptions drawn from the broad NAD+ description.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.